<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2223CB4A-352F-453E-AB94-8010D6C3F389"><gtr:id>2223CB4A-352F-453E-AB94-8010D6C3F389</gtr:id><gtr:firstName>William</gtr:firstName><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137961145"><gtr:id>A5911A01-8763-4DE9-8FFE-36A67640B9E9</gtr:id><gtr:title>Lineage commitment, erythropoietic differentiation and globin gene regulation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137961145</gtr:grantReference><gtr:abstractText>There are a number of genetic disorders of the blood cell protein, haemoglobin, that cause severe disease. In many parts of the world, these disorders are so common that they are a major public health problem. Treatment of affected individuals has improved but it is still far from satisfactory. An understanding of how the globin genes responsible for these disorders are regulated is a prerequisite to improved treatment.||We are developing mouse models in which the whole of the human a globin gene cluster replaces its mouse equivalent to study the regulation of the human genes.</gtr:abstractText><gtr:technicalSummary>Disorders of globin genes are among the most common genetic diseases worldwide and an understanding of how these genes are regulated is a prerequisite to improved treatment of patients with these disorders. We have set up a transgenic mouse facility to provide model systems to study this process and have demonstrated that even large pieces of the human a globin gene cluster inserted into mice are incompletely regulated. The major enhancer of human a globin gene expression has been identified by analysis of natural mutations and its mouse equivalent has also been identified. However, deletion of the mouse enhancer by knockout technology results in a much milder disease than its human counterpart, demonstrating that regulation of the mouse and human clusters have evolved separate mechanisms and that the mouse is not a good model for the human system. In order to overcome these problems we have helped develop (in conjunction with colleagues in Edinburgh) a technique in which the a globin gene region of the mouse has been excised and replaced with the equivalent region of the human cluster. This technique involves chromosome engineering in mouse ES cells and modification of a human BAC to produce mice humanised for a large region (&amp;gt;100 kb) around the a globin cluster. We have also produced humanised mice lacking the human enhancer element and demonstrated that they faithfully recapitulate the human disease. These mice will be used to purify erythroid cell populations at different stages of differentiation and maturation to analyse globin gene expression, chromatin structure, epigenetic modifications and other important facets of gene regulation. The findings will be compared with normal primary human erythroblasts produced from peripheral blood by a two stage culture system. The humanised mouse system is iterative, allowing successive modifications to the human BAC to be introduced into the ES cells and allow the generation of new mouse models. For instance, we plan to examine the orientation dependence of the major regulatory element in its natural location and determine the effects of moving the element to other positions both inside and outside the a globin gene cluster. This research project is at the basic end of the spectrum but the information obtained should be of benefit in designing future treatments of diseases such as the thalassaemias and sickle cell disease, particularly in terms of gene therapy.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1112636</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Sixth form talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DDA164A0-FFCB-45C0-BA26-B63F3656B5C1</gtr:id><gtr:impact>Debating the uses of animals in research

Widened discussion</gtr:impact><gtr:outcomeId>6D3AF26E8A0</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Radcliffe Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E57628CF-3326-4790-971D-2D5BD613DD4F</gtr:id><gtr:impact>XX</gtr:impact><gtr:outcomeId>58b96a59b408c2.31157978</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>172229</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Action Medical Research Project Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>29C26DD6-52E7-426A-9AD2-AAA158BED6C0</gtr:id><gtr:outcomeId>56d6f886df69a7.59025835</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>161673</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>095D7BCC-78FB-4643-810A-F5A92BDF2247</gtr:id><gtr:outcomeId>58b82b32dde1a5.73484466</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>248107</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Postdoctoral Training Fellowship for Clinician</gtr:description><gtr:end>2019-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>0C1EEFF6-BC9D-4FE7-80C5-4A211B027DBF</gtr:id><gtr:outcomeId>58b829dd302eb9.30460583</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Capital Bid 2015 - Molecular Haematology Unit</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>421CF0A2-ED2B-4F18-9F75-07C52CC0FAFC</gtr:id><gtr:outcomeId>58b827ca022237.33913406</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50679</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>wellcome Trust Institutional Strategic Support Fund</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>85DC77C2-D6C6-4F15-8E9A-C818B75A9478</gtr:id><gtr:outcomeId>58b825ee145667.43511995</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>242047</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Training Fellowship in Biomedical &amp;amp; Clinical Sciences</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9771BB1B-D194-464E-8A64-96825D9607F5</gtr:id><gtr:outcomeId>56d6f2b9181852.77197479</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Proximity to Discovery Industry Engagement</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>88C309A2-FAFF-4056-B474-DB2FF9570966</gtr:id><gtr:outcomeId>58b829305e8973.77600420</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council Public Engagement</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7EDF0A35-F8BA-401A-91F8-B494C8850D27</gtr:id><gtr:outcomeId>56d6f7dca82018.91263813</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>113981</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DPhil Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4F17C0F9-7625-473B-BE79-388BFF2B0FC4</gtr:id><gtr:outcomeId>58b826e7911905.82393700</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir Henry Wellcome postdoctoral Fellowship</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F833A862-B06F-4C6B-948E-67DBEDA24F31</gtr:id><gtr:outcomeId>56d6f8c47755f9.85529614</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2664612</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>1FB73D6E-4A53-41E6-91E8-74C5B4199255</gtr:id><gtr:outcomeId>56d6f84a7172f7.37040358</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>101789</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Institute Strategic Support Fund</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>BAE4A15F-B20F-42D1-A25E-C3156E1F27D0</gtr:id><gtr:outcomeId>58b8263e2b7fb9.28625493</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>223480</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust PhD Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>58D2E920-1ACD-4B76-BF5D-BC3EAF4A77EE</gtr:id><gtr:outcomeId>56d6f30744ec47.26280480</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>917526</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Institute of Health USA</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>433297DD-339C-41D6-9DDC-14A1A7195BE8</gtr:id><gtr:outcomeId>56d6f968abdbe7.29237019</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>E P A Cephalosporin Fund</gtr:department><gtr:description>EPA Cephalosporin Fund</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>654CBD40-217B-4BD6-A46D-7CDF270494DC</gtr:id><gtr:outcomeId>56d6f9b0416747.10800371</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>313000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Capital Bid - Weatherall Institute of Molecular Medicine</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DED4A2C5-309D-4B86-8FC9-4A1EC0A09C3A</gtr:id><gtr:outcomeId>58b82866d1c7c1.19695695</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences starter grant</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>F83B78DB-E6FC-40D9-9FF6-17A770C0AE39</gtr:id><gtr:outcomeId>56d6f90197d2f9.46424567</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4975434</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Oxford Single Cell Biology Consortium</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8DFDE6B5-A1EC-4092-BEEB-241C33816D4B</gtr:id><gtr:outcomeId>58b82741654fd5.34619073</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>265927</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Research Training Fellowship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>69118457-B514-4EF6-8AC1-3349421858DE</gtr:id><gtr:outcomeId>56d6feac952ab9.09417202</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>173793</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>Developing a programme for stem cell editing for human blood diseases</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>5032C318-7A37-4E3E-AC9B-C0C7898D1F8D</gtr:id><gtr:outcomeId>58b82aeab80948.02499603</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>82863</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MHU DPhil Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6CBF679D-5ADB-46FE-A287-03424D233E81</gtr:id><gtr:outcomeId>58b8268f4e7ab0.74525863</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>44639</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>VISION</gtr:description><gtr:end>2021-07-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>0F4208F3-B9B2-4C42-BE51-78E78F937AF8</gtr:id><gtr:outcomeId>58b82bb38a87b5.22451850</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>161117</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Four Year Phd Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A9EE3251-587A-4D89-A07D-1259D9B59CCF</gtr:id><gtr:outcomeId>56d6f812b50e63.41748809</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150135</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust ISSF Single Cell Biology in Oxford</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6A69560A-5657-4316-A727-A6E38F2D2E76</gtr:id><gtr:outcomeId>56d6f479b07f03.39810950</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>As described in Wallace et al Cell 2005</gtr:description><gtr:grantRef>MC_U137961145</gtr:grantRef><gtr:id>26C36E89-7FEB-407C-9257-EE3EE34C7BC6</gtr:id><gtr:impact>No impact as yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b82dc12a5a59.06050657</gtr:outcomeId><gtr:patentId>EP2099289</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Humanisation of Animals</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to the generation of transgenic animal cells and/or animals in which a large proportion of a host animal's genome has been replaced with an equivalent syntenic portion of nucleic acid from the genome of a different organism.</gtr:description><gtr:grantRef>MC_U137961145</gtr:grantRef><gtr:id>76D20841-9E20-4DF0-9226-8EB906C175CA</gtr:id><gtr:impact>European patent applied for</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>5A935612EB2</gtr:outcomeId><gtr:patentId>EP2099289</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Humanisation of Animals</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The IP covers the Next Generation Capture-C method for massively multiplexed 3C analysis of genome interactions</gtr:description><gtr:grantRef>MC_U137961145</gtr:grantRef><gtr:id>513E9540-2DD9-4C30-9456-F3AD2C745557</gtr:id><gtr:impact>None so far</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b82e1c2e1e38.60695333</gtr:outcomeId><gtr:patentId>PCT/GB2016/053314</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>NG Capture C</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A transgenic mouse in which a large mouse sequence (alpha globin cluster) has been replaced in situ with its equivalent human sequence.</gtr:description><gtr:id>9B21B065-07A4-426D-A55D-6E7048618D60</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>8CA17531F49</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Humanised mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B34050FB-EDDA-4B94-AE07-CD859A115C32</gtr:id><gtr:title>A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/176b59cd6681e624045d11349b7b0e8d"><gtr:id>176b59cd6681e624045d11349b7b0e8d</gtr:id><gtr:otherNames>De Gobbi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>CEC0D7CC0A0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86C79331-B9F0-4AD1-A8DA-EF0638D176C8</gtr:id><gtr:title>A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/408480e323b6cbd4b9562d0dd319ebf2"><gtr:id>408480e323b6cbd4b9562d0dd319ebf2</gtr:id><gtr:otherNames>Roy NB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>58b6af64e8b536.87164423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D474C348-B1F8-40ED-8BC4-629946BE7BF7</gtr:id><gtr:title>Multiplexed analysis of chromosome conformation at vastly improved sensitivity.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69710e756a65a120cb06d94fec106efb"><gtr:id>69710e756a65a120cb06d94fec106efb</gtr:id><gtr:otherNames>Davies JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>56d03d3c70cab5.12018559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>226202A8-0327-4500-9B33-108E4E8D16B0</gtr:id><gtr:title>DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ffbea2f52026736aa58c3be290fa8d5"><gtr:id>4ffbea2f52026736aa58c3be290fa8d5</gtr:id><gtr:otherNames>Jeziorska DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a99489398e3d0.82961220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80BA7F8A-49F5-40CC-AB99-D46ADC7EB94A</gtr:id><gtr:title>Tissue-specific CTCF-cohesin-mediated chromatin architecture delimits enhancer interactions and function in vivo.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e3320b997585e7ad96855a15436f7db"><gtr:id>3e3320b997585e7ad96855a15436f7db</gtr:id><gtr:otherNames>Hanssen LLP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>5a994893de3972.98665193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDB41F62-09E7-4183-AA44-937ED18C8DDC</gtr:id><gtr:title>a-Globin as a molecular target in the treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d03d3b7b7b30.81065154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1417E127-44ED-41E6-B835-B95F104AD224</gtr:id><gtr:title>Globin gene expression in Hb Lepore-BAC transgenic mice.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/843366cf72ab47f4b39a25ae6abd5536"><gtr:id>843366cf72ab47f4b39a25ae6abd5536</gtr:id><gtr:otherNames>Sloane-Stanley J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>F07461547AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BBA763E-7B30-4B27-9D00-EF245DEAF435</gtr:id><gtr:title>Gene Therapy in a Patient with Sickle Cell Disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bf76a708792d504446dea550778a37"><gtr:id>d8bf76a708792d504446dea550778a37</gtr:id><gtr:otherNames>Badat M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5aa7aa7b0b18a3.24605749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E1DBA77-4E8D-4221-BB23-B03B58CAC493</gtr:id><gtr:title>ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/461341f86b0010ce65b9c4daceda43e8"><gtr:id>461341f86b0010ce65b9c4daceda43e8</gtr:id><gtr:otherNames>Voon HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d03d3b30d975.84281615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB84420D-D6DD-4872-85A3-CEE883B2E83A</gtr:id><gtr:title>Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome.</gtr:title><gtr:parentPublicationTitle>Developmental dynamics : an official publication of the American Association of Anatomists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d72dd3d808c0e61e97ae41b202875ea9"><gtr:id>d72dd3d808c0e61e97ae41b202875ea9</gtr:id><gtr:otherNames>Twigg SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1058-8388</gtr:issn><gtr:outcomeId>B1B8F81969F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C2DDAAD-8467-4982-88B3-110EB17DA597</gtr:id><gtr:title>Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ab8e8f7d43db2d02f8fbaf90a095239"><gtr:id>4ab8e8f7d43db2d02f8fbaf90a095239</gtr:id><gtr:otherNames>Giustacchini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>5a34f662cba531.83770868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D05DDAF-8B64-476B-A747-2C52F0E7E212</gtr:id><gtr:title>An international registry of survivors with Hb Bart's hydrops fetalis syndrome.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a511347ce07fee54f2af7dab2b6ceb23"><gtr:id>a511347ce07fee54f2af7dab2b6ceb23</gtr:id><gtr:otherNames>Songdej D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5a994894b0a259.50551094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A508C6D-71D2-43AE-84D4-CC0F26DB1A5B</gtr:id><gtr:title>An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83eaa97aba73c726e5a7cf1d92e9ab36"><gtr:id>83eaa97aba73c726e5a7cf1d92e9ab36</gtr:id><gtr:otherNames>Blobel GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>56d03d3bdb01c9.50490020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1094EA12-2317-4AF5-AD0D-334827F80351</gtr:id><gtr:title>Genetic dissection of the a-globin super-enhancer in vivo.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4372a7f2d5ea1d6313b49e5c539a538"><gtr:id>f4372a7f2d5ea1d6313b49e5c539a538</gtr:id><gtr:otherNames>Hay D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b6af648844e9.80201951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6153BEEE-4BFD-4E3D-B716-DE1C16506BD9</gtr:id><gtr:title>Robust detection of chromosomal interactions from small numbers of cells using low-input Capture-C.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76bdd222d2fda6fbb041ce1329f33732"><gtr:id>76bdd222d2fda6fbb041ce1329f33732</gtr:id><gtr:otherNames>Oudelaar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a6f2de1316118.57486220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D50C76F-3DF7-4158-8D2E-3D12013D48D9</gtr:id><gtr:title>Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebfec82673c7594058286be4e6cab89f"><gtr:id>ebfec82673c7594058286be4e6cab89f</gtr:id><gtr:otherNames>Wallace HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>A6108999B4F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78439DB2-C70D-4FBD-9C2B-9391F052B6DB</gtr:id><gtr:title>Understanding a-globin gene regulation and implications for the treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>56d03d3ccc7693.50872447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF68A494-DED5-4855-8431-04DD8E6DC484</gtr:id><gtr:title>Editing an a-globin enhancer in primary human hematopoietic stem cells as a treatment for ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a994893441699.67498998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BAEFE22-EF2F-4D73-A590-CB57CB2AEE13</gtr:id><gtr:title>Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6109abc8918bd3707eccb11a639910b3"><gtr:id>6109abc8918bd3707eccb11a639910b3</gtr:id><gtr:otherNames>Ahmed MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>A49E2FDA573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>118F881C-95F6-4EEF-A229-1DADFB82280D</gtr:id><gtr:title>Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48237da23a0f64a5f2ba71ec22b9273a"><gtr:id>48237da23a0f64a5f2ba71ec22b9273a</gtr:id><gtr:otherNames>Muers MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>01A7C7592C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD2664A9-4646-4011-8A0F-80BD81EA9076</gtr:id><gtr:title>Functional characterisation of-regulatory elements governing dynamicexpression in the early mouse embryo.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b26b52cb6a8665efec9700003df5796"><gtr:id>7b26b52cb6a8665efec9700003df5796</gtr:id><gtr:otherNames>Simon CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>5a994894487f32.08085946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>734C9AD2-A85F-4D42-BF49-4ACE149B184A</gtr:id><gtr:title>Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f62bfcd0794a3cefbe9cae3c12f1a73e"><gtr:id>f62bfcd0794a3cefbe9cae3c12f1a73e</gtr:id><gtr:otherNames>Vernimmen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>4A2CD107EE1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A11AF60C-A19E-44BE-8E58-FEAE72F45C67</gtr:id><gtr:title>Newborn Screening for Sickle Cell Disease: Jamaican Experience.</gtr:title><gtr:parentPublicationTitle>The West Indian medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e6fd9fb38995a694e6e0235e807ea2a"><gtr:id>2e6fd9fb38995a694e6e0235e807ea2a</gtr:id><gtr:otherNames>Mason K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0043-3144</gtr:issn><gtr:outcomeId>56d03d3d4451e8.23464677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CCA6817-0FF8-4CE8-A804-540F5B0D9803</gtr:id><gtr:title>Haemoglobin Variant Screening in Jamaica: Meeting Student's Request.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e6fd9fb38995a694e6e0235e807ea2a"><gtr:id>2e6fd9fb38995a694e6e0235e807ea2a</gtr:id><gtr:otherNames>Mason K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>56d03d3bab9875.64868857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85018124-181B-4751-AE40-9C2A65CE0500</gtr:id><gtr:title>Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e0b20cfc0518dfe2421077726527510"><gtr:id>8e0b20cfc0518dfe2421077726527510</gtr:id><gtr:otherNames>Karamitros D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5a9ea57fa5bc31.80737550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83D7003A-FEA3-4E17-B2D4-C3D5B31C6CF6</gtr:id><gtr:title>Beta thalassaemia intermedia due to co-inheritance of three unique alpha globin cluster duplications characterised by next generation sequencing analysis.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/722f30aecd71f1a59c1ba6e08566ee25"><gtr:id>722f30aecd71f1a59c1ba6e08566ee25</gtr:id><gtr:otherNames>Clark B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>58b6af643bb9c8.12807708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>546CF650-6F0E-4616-99D1-BF5302466923</gtr:id><gtr:title>Kr&amp;uuml;ppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09541d5782fbcf282cf795127548298"><gtr:id>b09541d5782fbcf282cf795127548298</gtr:id><gtr:otherNames>Perkins A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d03d3d6e8c52.23039500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32869AF5-343E-4AFC-A3A8-13CFE2C396D7</gtr:id><gtr:title>Association between active genes occurs at nuclear speckles and is modulated by chromatin environment.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5972aac6e4f4128eb96dcaf53080fb8"><gtr:id>b5972aac6e4f4128eb96dcaf53080fb8</gtr:id><gtr:otherNames>Brown JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>33EBCF36F0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64B3C5A7-9139-4929-BDD3-73E0AAA6CB64</gtr:id><gtr:title>How transcriptional and epigenetic programmes are played out on an individual mammalian gene cluster during lineage commitment and differentiation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0067-8694</gtr:issn><gtr:outcomeId>75E2BB18AD5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F4A3BB2-AD48-4B82-8FBD-9CE35D585348</gtr:id><gtr:title>How best to identify chromosomal interactions: a comparison of approaches.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69710e756a65a120cb06d94fec106efb"><gtr:id>69710e756a65a120cb06d94fec106efb</gtr:id><gtr:otherNames>Davies JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>5a994894880936.79956951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56C50F32-4FD4-4C2D-B0E5-4C662AD910A6</gtr:id><gtr:title>Molecular Basis and Genetic Modifiers of Thalassemia.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>5a994892d59272.68598540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1D1D78F-AFE3-4B81-ACDD-C8045B2CD831</gtr:id><gtr:title>A novel deletion causing alpha thalassemia clarifies the importance of the major human alpha globin regulatory element.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92d22eef053522284356ca6d29e0e206"><gtr:id>92d22eef053522284356ca6d29e0e206</gtr:id><gtr:otherNames>Viprakasit V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>8CD63A96DD8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B06B3CDE-EA6B-4E79-92A7-F7984A2C226D</gtr:id><gtr:title>Tissue-specific histone modification and transcription factor binding in alpha globin gene expression.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/176b59cd6681e624045d11349b7b0e8d"><gtr:id>176b59cd6681e624045d11349b7b0e8d</gtr:id><gtr:otherNames>De Gobbi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>83D18086FF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>975AF00F-342B-465B-9C3E-33277E2B2659</gtr:id><gtr:title>Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f02c021074de23ceff430d6ed7c73ada"><gtr:id>f02c021074de23ceff430d6ed7c73ada</gtr:id><gtr:otherNames>Masuda T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56d03d3d0b0969.96461775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>977CF145-4E25-4762-9862-50E1EC32E005</gtr:id><gtr:title>The congenital dyserythropoietic anemias.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4adc4b631bc76506c24ee2871ccf5b91"><gtr:id>4adc4b631bc76506c24ee2871ccf5b91</gtr:id><gtr:otherNames>Renella R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>58B04851823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DBD60C5-A993-4CDA-80E2-945DCE9A3107</gtr:id><gtr:title>Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b62f919c1ce48564e23cc6ba86f4ad99"><gtr:id>b62f919c1ce48564e23cc6ba86f4ad99</gtr:id><gtr:otherNames>Garrick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>C6C808B4DEB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18C0DFDC-B9C8-41C3-83AC-5DB38B27AF90</gtr:id><gtr:title>Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0595a7d8bf7c30b67c83c71fcc8d9e98"><gtr:id>0595a7d8bf7c30b67c83c71fcc8d9e98</gtr:id><gtr:otherNames>Taylor JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5675e4a88f713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EB3986C-0DC3-4635-AA95-F2BE081E191D</gtr:id><gtr:title>Between form and function: the complexity of genome folding.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76bdd222d2fda6fbb041ce1329f33732"><gtr:id>76bdd222d2fda6fbb041ce1329f33732</gtr:id><gtr:otherNames>Oudelaar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a99489312a410.46080668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A39D8FEB-A8EE-49AB-B676-D3ADCCD6EDB9</gtr:id><gtr:title>Phenotypic and molecular characterization of a serum-free miniature erythroid differentiation system suitable for high-throughput screening and single-cell assays.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>5a6792b05d63d2.24437910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6BC8078-27B2-44F9-9B1F-9EF96438E08D</gtr:id><gtr:title>Long-range regulation of alpha globin gene expression during erythropoiesis.</gtr:title><gtr:parentPublicationTitle>Current opinion in hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1065-6251</gtr:issn><gtr:outcomeId>DDC830FBCF9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4F40CCA-90C4-4BB4-A44B-65C57D3E2148</gtr:id><gtr:title>Studying epigenomics in single cells: what is feasible and what can we learn?</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>56d03d3ca47976.64575634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0253BDD7-20E1-4656-8061-D43E50E216F1</gtr:id><gtr:title>Coregulated human globin genes are frequently in spatial proximity when active.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5972aac6e4f4128eb96dcaf53080fb8"><gtr:id>b5972aac6e4f4128eb96dcaf53080fb8</gtr:id><gtr:otherNames>Brown JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>7A656AF93A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC6C18CD-6D3D-48BC-9476-6DD45CBA36A9</gtr:id><gtr:title>Selective silencing of a-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>58b6af64c81418.65892648</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137961145</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>